Dora Markati
MD, DPhil
Postdoctoral Research Associate
Dora is a clinician-scientist and postdoctoral researcher in the Rinaldi Lab at the University of Oxford. Her research focuses on developing innovative DNA- and RNA-targeting therapies for rare neurodevelopmental disorders. She has expertise in therapeutic development, particularly CRISPR-based approaches and antisense oligonucleotides, as well as in disease modelling using patient-derived systems.
She completed her DPhil in Paediatrics at the University of Oxford, during which she led one of the largest natural history studies in Angelman syndrome to advance biomarker and outcome measure development for clinical trials.
She earned her medical degree in 2016 and went on to complete an MPhil in Biological Science at the University of Cambridge in 2020, where she investigated molecular mechanisms of nervous system development. Clinically, Dora has trained in General Paediatrics and Neonatology at leading hospitals in London and Cambridge. She has also served as an investigator in early-phase clinical trials for rare neurogenetic diseases.
